Senti Biosciences Completes Convertible Note Issuance and Enters Equity Commitment

Filing content

Senti Biosciences completed the issuance of $2.0 million in senior secured convertible notes and entered into an equity commitment letter to sell $2.5 million of common stock at the time of the merger closing.